Asia Green Biotechnology Corp. announced a private placement with a director of the company for aggregate gross proceeds of CAD 400,000 on August 3, 2021. The company will issue convertible debenture for CAD 200,000 in the first element of the financing and will issue 2,500,000 units at a price of CAD 0.08 per unit for gross proceeds to the company of CAD 200,000 in its second element of the financing. The debenture carries an interest rate of 12% and is convertible at any time after the date of issue at the option of the lender into common shares in the capital of the company at a price of CAD 0.08 per common share. After 24 months following the date of issue, if the common shares trade at or above CAD 0.25, based on the trailing 30-day volume-weighted average price of the common shares traded on the CSE, the company will have the right, exercisable within 10 business days of the end of the trading period, to require the automatic conversion of the debentures at the conversion price by giving the holder 10 business days' prior written notice. The debentures are repayable on demand on 10 business days' notice to the Company in the event of a change of control of the company. Each unit is comprised of a common treasury share and one common share purchase warrant of the company. Each warrant entitles the holder thereof to acquire one common share at a price of CAD 0.15 per share for a period of 24 months from the date of issue. The company also engaged Market speak of 15 Iceboat Terrace, to provide certain investor relations services for the company. Market Speak will assist the corporation by providing introductions to investment groups and individuals and assisting the corporation with investor and shareholder communications. The company will grant Market speak an option to purchase up to 200,000 common shares at an exercise price of CAD 0.20 per share, will pay an initial fee of CAD 10,000 and will reimburse Market speak for any reasonable expenses incurred in carrying out its obligations under the agreement.